Jupiter Life Line Hospitals Limited share price

Key numbers

Market cap

₹ 8,709 Cr

Current price

₹ 265.65

52-week high / low

₹ 340 / 236

Stock P/E

46.5

Book value

₹ 47.1

Dividend yield

0.08%

ROCE

14.8%

ROE

13.4%

Debt to equity

0.38

Sales growth (3 yrs)

18.9%

Profit growth (3 yrs)

38.6%

1-year return

-12.5%

About Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel brand in Thane. The company was incorporated in 2002 and is based in Mumbai, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-07)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• This quarter has contributed to a INR9.5 crores drag on the EBITDA, pretty much in line with anticipation.
• So the higher cost this quarter is on account of anticipated growth in the rest of the year and higher HR-related costs.

Growth & demand

• Just wanted to understand, while the revenue growth of 10%, we understand on a higher base last year, the EBITDA margins have come in at a lower 12%.
• Thane unit is stic k around mid-70% occupancy, 75%-odd, which means that it will only improve in line with inflationary pricing, not leaving too much more growth opportunity besides that.

Margins & costs

• The EBITDA stood at INR79.3 crores and with a margin of 19.3%.
• Fixed cost, I think, should be INR6 crores, INR7 crores for a month currently.

Capex & expansion

• Hi, Dhvani, so Indore, as I said, we are getting ready for the next phase of expansion.
• After that, once we reach an operational occupancy of about 60% of the installed beds, we will add capex and add capacity to the tune that the occupancy falls down to, let us say, around 40%.

Balance sheet & cash

• So FY '26, you had gross debt of, say, almost INR509 crores.
• Currently, the board -imposed ceiling is debt of 3x of EBITDA, but we think that we should be able to complete the current round well within that range.

Peers in Medical Care Facilities

• Apollo Hospitals Enterprise Limited
• Max Healthcare Institute Limited
• Manipal Health Enterprises Limited
• Aster DM Quality Care Limited
• Fortis Healthcare Limited
• Global Health Limited
• Narayana Hrudayalaya Limited
• Krishna Institute of Medical Sciences Limited
• Rainbow Children's Medicare Limited
• Park Medi World Limited